EXHIBIT 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Bone Biologics Corporation
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities and Carry Forward Securities
Security Type | | Security Class Title | | Fee Calculation or Carry Forward Rule | | | Amount Registered | | | Proposed Maximum Offering Price Per Unit | | | Maximum Aggregate Offering Price | | | Fee Rate | | | Amount of Registration Fee | |
Equity | | Common Stock, par value $0.001 per share | | | 457(c) | | | | 142,384 | (1) | | $ | 4.32 | (2) | | $ | 615,099 | (2) | | | .00014760 | | | $ | 91 | |
Total Offering Amounts | | | | | | | $ | 615,099 | | | | | | | $ | 91 | |
Net Fee Due | | | | | | | | | | | | | | | $ | 91 | |
(1) | Pursuant to Rule 416 of the Securities Act, the securities registered hereunder include such indeterminate number of additional shares of Common Stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. |
| |
(2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”). The price per share and aggregate offering price are based on the average of the high ($4.60) and low ($4.03) prices of the Common Stock reported on the Nasdaq Stock Market on January 2, 2024. |